Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/11/2017 10/12/2017 10/13/2017 10/16/2017 10/17/2017 Date
118.64(c) 120.63(c) 119.7(c) 119.51(c) 119.39 Last
918 217 1 486 018 798 696 1 352 374 187 103 Volume
+0.19% +1.68% -0.77% -0.16% -0.10% Change
More quotes
Financials ($)
Sales 2017 7 831 M
EBIT 2017 2 438 M
Net income 2017 1 032 M
Debt 2017 9 461 M
Yield 2017 0,82%
Sales 2018 8 065 M
EBIT 2018 2 516 M
Net income 2018 1 383 M
Debt 2018 8 304 M
Yield 2018 0,87%
P/E ratio 2017 24,76
P/E ratio 2018 18,93
EV / Sales2017 4,29x
EV / Sales2018 4,03x
Capitalization 24 164 M
More Financials
Company
Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products, sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products.The company operates through three geographical segments:... 
More about the company
Surperformance© ratings of Zimmer Biomet Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ZIMMER BIOMET HOLDINGS INC
10/13 ZIMMER BIOMET : Daily Technical Summary Reports on Medical Equipment Stocks -- I..
10/12 ZIMMER BIOMET : Announces Audio Webcast and Conference Call of Third Quarter 201..
10/10 ZIMMER BIOMET : Announces Audio Webcast and Conference Call of Third Quarter 201..
10/06 ZIMMER BIOMET : Provides Update on Manufacturing Facilities in Guaynabo and Ponc..
10/04 ZIMMER BIOMET : Provides Update on Manufacturing Facilities in Guaynabo and Ponc..
10/04 ZIMMER BIOMET : Announces U.S. Launch of Avenue T TLIF Cage with Integrated Vert..
10/02 ZIMMER BIOMET : Announces U.S. Launch of Avenue® T TLIF Cage with Integrated Ver..
09/28 ZIMMER BIOMET HOLDINGS, INC. (NYSE : ZBH) Files An 8-K Entry into a Material Def..
09/28 ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creat..
09/21 ZIMMER BIOMET HOLDINGS INC : ex-dividend day
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10/16Zimmer Biomet Holdings, Inc. $ZBH Stake Lowered by Bank of Nova Scotia  
10/15$ZBH - Zimmer Biomet Holdings, Inc. #ZBH Holdings Cut by Hall Laurie J Truste.. 
10/15$ZBH - Zimmer Biomet Holdings, Inc. Forecasted to Earn Q3 2017 Earnings of $1.. 
10/15Zimmer Biomet Holdings, Inc. Forecasted to Earn Q3 2017 Earnings of $1.72 Per.. 
10/14Beaton Management Co. Inc. Buys Shares of 2,300 Zimmer Biomet Holdings, Inc. .. 
More tweets
Qtime:289
News from SeekingAlpha
10/12 Wright Can't Get It Right
10/09 First meeting of new FDA advisory committee this week
09/29 ZIMMER BIOMET : A Leading Medtech Player Facing Short-Term Issues
09/14 Dividend Champion, Contender And Challenger Stocks Going Ex-Div Next Week (Se..
09/01 ZIMMER BIOMET HOLDINGS : Undervalued And Unloved
Chart ZIMMER BIOMET HOLDINGS INC
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Technical analysis trends ZIMMER BIOMET HOLDINGS INC
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 135 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Daniel P. Florin Director, Chief Executive & Financial Officer
Larry C. Glasscock Non-Executive Chairman
Adrian Furey Senior VP-Global Operations & Logistics
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Arthur Joseph Higgins Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS INC15.99%24 164
MEDTRONIC PLC9.60%105 292
BAXTER INTERNATIONAL41.68%34 681
C R BARD INC43.94%23 493
HOYA CORPORATION27.19%21 742
TERUMO CORP7.86%15 788